Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
CNBC's Jim Cramer sits down with CVS Health CEO David Joyner to discuss the company's investor day, how healthcare technology is changing, the role of artificial intelligence and more.
Unvaccinated residents can receive a measles vaccine at select CVS Pharmacy and MinuteClinic locations across the state WOONSOCKET, R.I. , Dec. 11, 2025 /PRNewswire/ -- As South Carolina public health
CVS Health Corporation (CVS) Analyst/Investor Day Prepared Remarks Transcript

Cramer's Stop Trading: CVS Health

10:36am, Wednesday, 10'th Dec 2025
CNBC's Jim Cramer explains why he is keeping an eye on shares of CVS Health.

Buy Or Fear CVS Stock At $78?

09:00am, Wednesday, 10'th Dec 2025
CVS Health's (NYSE: CVS) latest results affirm several points: their sales and adjusted profits remain stable, and they are adjusting their forecasts upward. Nonetheless, the quality of their profits
Ardsley Advisory Partners LP bought a new position in shares of CVS Health Corporation (NYSE: CVS) in the second quarter, according to the company in its most recent disclosure with the Securities and
Ariel Investments LLC lifted its holdings in CVS Health Corporation (NYSE: CVS) by 14.2% in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange C
CVS Health Corporation (NYSE: CVS - Get Free Report)'s share price gapped up before the market opened on Tuesday after Wolfe Research raised their price target on the stock from $85.00 to $100.00. The
Stock News Fed set for ‘hawkish cut': Goldman Sachs (GS) and other Wall Street desks expect the Federal Reserve to deliver a third straight 25 bps rate cut wh
CVS wants investors to know it sees bigger profits ahead, and has new AI plans.
CVS Health is positioned for continued outperformance, with a strong turnaround driving industry-leading results and a reiterated "Buy" rating. CVS's Q3 showed 7.8% revenue growth, 47% adjusted EPS gr
Famed investor Jim Cramer says he “salutes” DaviCVSd Joyner after CVS Health (NYSE: CVS) raised its profit guidance for 2026 – reinforcing the new management's turnaround plan is starting to bea
CVS Health (CVS) has raised its fiscal year 2025 outlook, increasing EPS to $6.60–$6.70 from $6.55–$6.65, and revenue to at least $400 billion from $397.3 b
CVS Health Corporation is a top S&P 500 performer in 2025, up 78% YTD, with strong operational and financial momentum. I reiterate a Buy rating for CVS, raising my intrinsic value target to $93, based
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE